BREAKING NEWS (1/17/2008): AÂ lawsuit has been filed by the law firm ofÂ Parker Waichman LLP to get a refund for those who use Vytorin.
The makers of Vytorin have been named as defendants in a lawsuit filed by a New York man who took the defective drug based on the belief that it offered more protection from clogged arteries, heart attacks and strokes than other, less expensive statin drugs. Sigmond Tomaszewski, who began taking Vytorin in January 2007, alleges that Merck and Schering-Plough knew in April 2006 that Vytorin was ineffective at reducing artery clogging plaque, heart attacks and strokes, but purposely kept that information from the public and the medical community. Tomaszewski is being represented by the law firm of Parker Waichman LLP…
1/16/08Â Letter from Congress to Schering-Plough Merck PDF
1/16/08Â Letter from Congress to FDA PDF
1/22/08Â Letter from Congress to Centers For Medicare and Medicaid Services PDF
1/22/08Â Letter from Congress to Schering-Plough Merck PDF